~~<i id='48663C7DA8'><strike id='48663C7DA8'><tt id='48663C7DA8'><pre id='48663C7DA8'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：comprehensive 2025-08-15 09:12:08 Page View：5344

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Emergency medicine has repudiated 'excited delirium.' Now what?
Next article： Affirmative action in medical school literally saved lives

explore

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Eli Lilly to pay $200M for Beam’s stake in gene

AdobeEliLillysaidTuesdaythatitwillpay$200milliontogene-editingfirmBeamTherapeuticsforBeam’sstakeinVe

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

Ambulance rides for just $100? Advisers want major billing fixes

AdobeApanelofgovernmentadvisersfinallyhasendorsedideasforCongresstosolvetheparticularlythornyproblem